Filing Details
- Accession Number:
- 0001567619-23-001284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-25 20:54:15
- Reporting Period:
- 2023-01-23
- Accepted Time:
- 2023-01-25 20:54:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1574218 | John Thomas Dietz | C/O Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-23 | 50,000 | $1.43 | 50,000 | No | 4 | P | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 21,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- These shares are held directly by the Dietz Family Trust, for which the reporting person and his spouse serve as co-trustees.
Billionaire Hedge Funds
